These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17828376)

  • 1. The role of autocrine motility factor in tumor and tumor microenvironment.
    Funasaka T; Raz A
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):725-35. PubMed ID: 17828376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complex biology of autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and its receptor, the gp78/AMFR E3 ubiquitin ligase.
    Fairbank M; St-Pierre P; Nabi IR
    Mol Biosyst; 2009 Aug; 5(8):793-801. PubMed ID: 19603112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor autocrine motility factor is an angiogenic factor that stimulates endothelial cell motility.
    Funasaka T; Haga A; Raz A; Nagase H
    Biochem Biophys Res Commun; 2001 Jul; 285(1):118-28. PubMed ID: 11437381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor autocrine motility factor induces hyperpermeability of endothelial and mesothelial cells leading to accumulation of ascites fluid.
    Funasaka T; Haga A; Raz A; Nagase H
    Biochem Biophys Res Commun; 2002 Apr; 293(1):192-200. PubMed ID: 12054583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy.
    Yanagawa T; Funasaka T; Tsutsumi S; Watanabe H; Raz A
    Endocr Relat Cancer; 2004 Dec; 11(4):749-59. PubMed ID: 15613449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine motility factor secreted by tumor cells upregulates vascular endothelial growth factor receptor (Flt-1) expression in endothelial cells.
    Funasaka T; Haga A; Raz A; Nagase H
    Int J Cancer; 2002 Sep; 101(3):217-23. PubMed ID: 12209971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine motility factor signaling enhances pancreatic cancer metastasis.
    Tsutsumi S; Yanagawa T; Shimura T; Kuwano H; Raz A
    Clin Cancer Res; 2004 Nov; 10(22):7775-84. PubMed ID: 15570012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMF/G6PI induces differentiation of leukemic cells via an unknown receptor that differs from gp78.
    Haga A; Komazaki S; Funasaka T; Hashimoto K; Yokoyama Y; Watanabe H; Raz A; Nagase H
    Leuk Lymphoma; 2006 Oct; 47(10):2234-43. PubMed ID: 17071500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor autocrine motility factor responses are mediated through cell contact and focal adhesion rearrangement in the absence of new tyrosine phosphorylation in metastatic cells.
    Silletti S; Paku S; Raz A
    Am J Pathol; 1996 May; 148(5):1649-60. PubMed ID: 8623932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possibility that AMF will serve as a target molecule for the diagnosis and treatment of a metastatic neoplasm].
    Haga A
    Yakugaku Zasshi; 2005 Feb; 125(2):169-75. PubMed ID: 15684571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia.
    Funasaka T; Yanagawa T; Hogan V; Raz A
    FASEB J; 2005 Sep; 19(11):1422-30. PubMed ID: 16126909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor autocrine motility factor is an angiogenic factor hat stimulates endothelial cell motility.
    Funasaka T; Haga A; Raz A; Nagase H
    Biochem Biophys Res Commun; 2001 Jun; 284(5):1116-25. PubMed ID: 11414699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of small GTPase Rho is required for autocrine motility factor signaling.
    Tsutsumi S; Gupta SK; Hogan V; Collard JG; Raz A
    Cancer Res; 2002 Aug; 62(15):4484-90. PubMed ID: 12154059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raft-dependent endocytosis of autocrine motility factor/phosphoglucose isomerase: a potential drug delivery route for tumor cells.
    Kojic LD; Wiseman SM; Ghaidi F; Joshi B; Nedev H; Saragovi HU; Nabi IR
    PLoS One; 2008; 3(10):e3597. PubMed ID: 18974847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor cell autocrine motility factor receptor.
    Nabi IR; Watanabe H; Silletti S; Raz A
    EXS; 1991; 59():163-77. PubMed ID: 1655517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cell motility via high and low affinity autocrine motility factor (AMF) receptor in human oral squamous carcinoma cells.
    Niinaka Y; Haga A; Negishi A; Yoshimasu H; Raz A; Amagasa T
    Oral Oncol; 2002 Jan; 38(1):49-55. PubMed ID: 11755821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of phosphoglucose isomerase/autocrine motility factor activities by the poly(ADP-ribose) polymerase family-14.
    Yanagawa T; Funasaka T; Tsutsumi S; Hu H; Watanabe H; Raz A
    Cancer Res; 2007 Sep; 67(18):8682-9. PubMed ID: 17875708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins.
    Torimura T; Ueno T; Kin M; Harada R; Nakamura T; Kawaguchi T; Harada M; Kumashiro R; Watanabe H; Avraham R; Sata M
    Hepatology; 2001 Jul; 34(1):62-71. PubMed ID: 11431735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autocrine motility factor receptor gene expression and cell motility in lung cancer cell lines.
    Takanami I; Takeuchi K; Watanabe H; Yanagawa T; Takagishi K
    Oncol Rep; 2002; 9(1):125-8. PubMed ID: 11748469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of autocrine motility factor receptor in metastasis].
    Watanabe H; Chigira M; Raz A
    Gan To Kagaku Ryoho; 1993 Feb; 20(3):405-9. PubMed ID: 8382466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.